A Study of QL1706 in Subjects With Advanced Malignant Tumor

Clinical trial NCT04296994 · UNKNOWN

Trial details

NCT number: NCT04296994
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2020-03-31
Primary completion: 2021-12-31
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.